10 Reasons Engineers Paying $1,247/Month Are Switching to Onavya

Think of your body as a sailboat. The medication is making the sail bigger — the cardiovascular work, the A1C drop, the forty-one pounds. The hull is what the wind acts on. The medication strips the hull of what slows the boat — the fat. It also strips it of what holds the plates together — the muscle. Across the trial data the lean fraction runs around 20-40% of total weight lost. (Per the 2021 trial known as Wilding STEP 1.)

Protein gives the bricks. Resistance training tells them where to go. Necessary. But there's a layer underneath the bricks — the cellular furnaces inside every muscle cell. When the body is held in a sustained calorie deficit, those furnaces slow down. Protein doesn't reach them. Lifting doesn't reach them. Even disciplined buyers lose 15-25% lean. (Researchers call that layer the mitochondrial biogenesis axis — the cells' factory line for new furnaces.)

You watched fish oil, B-12, turmeric, milk thistle, CoQ10, and NAC stand on a kitchen counter for forty years. None of them touched the cellular furnace line. They worked on inflammation, on circulation, on liver enzymes. Real benefits, real targets — and a different floor of the same building. The eye-roll you carried for forty years was earned. It's just that the floor the spreadsheet pointed to was never on those labels.

Your endocrinologist said the literature was starting to flag lean-mass loss and that it was "worth keeping an eye on." That isn't a plan. It's a note in the margin. The cellular layer doesn't reset on its own under a sustained deficit — the math the spreadsheet wanted needed a mechanism, not a margin note. A different molecule, on a different floor, at a defined dose.

Your muscle cells have walls. Most antioxidants protect only the outside. Astaxanthin is small enough and oily enough to sit inside the wall itself — including the wall around the cellular furnaces. Once it's there, it helps the furnaces hold their pace and protects the fibers that lose strength first under a calorie deficit. One molecule. Two jobs on the floor protein and lifting can't reach. (The science calls these PGC-1α support + type-II fiber oxidative protection.)

A 2018 randomized trial took adults aged 65 to 82 with measured muscle decline and split them in two groups. Both did light exercise. The group that added 12mg of this carotenoid for twelve weeks gained 14% strength, 40% endurance, and 8% mobility. The exercise-only group gained zero strength. Zero is the kind of number that closes a math problem. (Liu 2018 on PubMed — full citation in the footnote below.)

The trial used 12 milligrams a day, from natural microalgae. Most astaxanthin softgels on the shelf sell 4 to 6mg — barely a third of what the researchers used. Onavya delivers the full 12mg in a single softgel, sourced from a microalgae called Haematococcus pluvialis (the same form the trial used) and paired with oil so your body actually absorbs it. No filler. No 4mg shortcut.

A 2020 review pooled twenty studies on this carotenoid and muscle health. The picture was consistent: less oxidative stress inside the muscle cell, slower breakdown of muscle protein, and more new cellular factories being built. (Wong, Ima-Nirwana, Chin 2020 on PubMed.) That's the layer the spreadsheet pointed to — described, measured, and mapped in twenty separate papers.

Run the line. The medication runs about $40 a day out-of-pocket. The molecule on the floor below runs $1.17 a day on the single pouch — or ninety-four cents a day on the three-pouch. Less than a tenth of the daily cost of the prescription you are already paying for. The boat is the boat. The hull is what the wind acts on. The cost-benefit on the hull is the line at the bottom of the yellow pad.

Take it for twelve weeks — the same window the published trial tracked. Let your endocrinologist read the next DEXA. If the lean row hasn't turned the right way, full refund, no questions, no fine print. The eye-roll you carried for forty years was earned. The math at the desk at 11:47 PM was earned too. The risk lives on our side, not on the next column of your spreadsheet.